Vaccines are different: A systematic review of budget impact analyses of vaccines (2017)
- Authors:
- USP affiliated authors: SARTORI, ANA MARLI CHRISTOVAM - FM ; SOÁREZ, PATRÍCIA COELHO DE - FM ; NOVAES, HILLEGONDA MARIA DUTILH - FM
- Unidade: FM
- DOI: 10.1016/j.vaccine.2017.03.088
- Subjects: VACINAS; REVISÃO SISTEMÁTICA; CUSTO ECONÔMICO; IMUNIZIÇÃO
- Language: Inglês
- Imprenta:
- Publisher place: Kidlington
- Date published: 2017
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
LOZE, Priscilla Magalhaes et al. Vaccines are different: A systematic review of budget impact analyses of vaccines. Vaccine, v. 35, n. 21, p. 2781-2793, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2017.03.088. Acesso em: 26 jan. 2026. -
APA
Loze, P. M., Nasciben, L. B., Sartori, A. M. C., Itria, A., Novaes, H. M. D., & Soárez, P. C. de. (2017). Vaccines are different: A systematic review of budget impact analyses of vaccines. Vaccine, 35( 21), 2781-2793. doi:10.1016/j.vaccine.2017.03.088 -
NLM
Loze PM, Nasciben LB, Sartori AMC, Itria A, Novaes HMD, Soárez PC de. Vaccines are different: A systematic review of budget impact analyses of vaccines [Internet]. Vaccine. 2017 ; 35( 21): 2781-2793.[citado 2026 jan. 26 ] Available from: https://doi.org/10.1016/j.vaccine.2017.03.088 -
Vancouver
Loze PM, Nasciben LB, Sartori AMC, Itria A, Novaes HMD, Soárez PC de. Vaccines are different: A systematic review of budget impact analyses of vaccines [Internet]. Vaccine. 2017 ; 35( 21): 2781-2793.[citado 2026 jan. 26 ] Available from: https://doi.org/10.1016/j.vaccine.2017.03.088 - Systematic review of economic evaluations of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in individuals 60 years of age or older
- Revisão sistemática das diretrizes de análise de impacto
- Challenges of interpreting epidemiologic surveillance pertussis data with changing diagnostic and immunization practices: the case of the state of Sao Paulo, Brazil
- Systematic review of cost-effectiveness of vaccinating elderly whit the 23-valent pneumococcal polysaccharide vaccine (PPV23)
- Cost-Effectiveness Analysis of Universal Vaccination of Adults Aged 60 Years with 23-Valent Pneumococcal Polysaccharide Vaccine versus Current Practice in Brazil
- Polio inactivated vaccine costs into routine childhood immunization in Brazil
- Methods and challenges for the health impact assessment of vaccination programs in Latin America
- Annual national direct and indirect cost estimates of the prevention and treatment of cervical cancer in Brazil
- Economic evaluation of adolescents and adults' pertussis vaccination: a systematic review of current strategies
- Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil
Informações sobre o DOI: 10.1016/j.vaccine.2017.03.088 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
